Inventor · disambiguated record
Reini Hurme
Also filed as: HURME REINI
18 granted patents·4 pending applications·17 citations·filing 2011–2024
90Inventor score
Top patents by PatentIndex Score
22 records- 0189US12025623B2Lipidomic biomarkers for atherosclerosis and cardiovascular diseaseZORA BIOSCIENCES OY·Filed 2019·Granted Jul 2, 2024·2 cites·23 claims
- 0288US2024385201A1Lipidomic biomarkers for atherosclerosis and cardiovascular diseaseZORA BIOSCIENCES OY·Filed 2024·Application pending·0 cites
- 0383US9046538B2Lipidomic biomarkers for atherosclerosis and cardiovascular diseaseLAAKSONEN REIJO·Filed 2011·Granted Jun 2, 2015·8 cites·15 claims
- 0481US10551394B2Lipidomic biomarkers for atherosclerosis and cardiovascular diseaseZORA BIOSCIENCES OY·Filed 2017·Granted Feb 4, 2020·2 cites·26 claims
- 0575US12270816B2Lipidomic biomarkers for identification of high-risk coronary artery disease patientsZORA BIOSCIENCES OY·Filed 2021·Granted Apr 8, 2025·0 cites·14 claims
- 0671US10955427B2Lipidomic biomarkers for identification of high-risk coronary artery disease patientsZORA BIOSCIENCES OY·Filed 2019·Granted Mar 23, 2021·0 cites·30 claims
- 0770US9201080B2Lipidomic biomarkers for identification of high-risk coronary artery disease patientsLAAKSONEN REIJO·Filed 2011·Granted Dec 1, 2015·1 cites·18 claims
- 0869US9052328B2Lipidomic biomarkers for the prediction of cardiovascular outcomes in coronary artery disease patients not undergoing statin treatmentZORA BIOSCIENCES OY·Filed 2012·Granted Jun 9, 2015·1 cites·15 claims
- 0969US9052327B2Lipidomic biomarkers for the prediction of cardiovascular outcomes in coronary artery disease patients undergoing statin treatmentZORA BIOSCIENCES OY·Filed 2012·Granted Jun 9, 2015·1 cites·15 claims
- 1067US9541565B2Biomarkers for sensitive detection of statin-induced muscle toxicityLAAKSONEN REIJO·Filed 2011·Granted Jan 10, 2017·1 cites·20 claims
- 1164US9664698B2Biomarkers for sensitive detection of statin-induced muscle toxicityLAAKSONEN REIJO·Filed 2011·Granted May 30, 2017·1 cites·15 claims
- 1261US9863965B2Lipidomic biomarkers for the prediction of cardiovascular outcomes in coronary artery disease patients not undergoing statin treatmentZORA BIOSCIENCES OY·Filed 2016·Granted Jan 9, 2018·0 cites·30 claims
- 1360US10261101B2Lipidomic biomarkers for identification of high-risk coronary artery disease patientsZORA BIOSCIENCES OY·Filed 2017·Granted Apr 16, 2019·0 cites·21 claims
- 1459US9857386B2Lipidomic biomarkers for atherosclerosis and cardiovascular diseaseZORA BIOSCIENCES OY·Filed 2016·Granted Jan 2, 2018·0 cites·25 claims
- 1559US9423406B2Lipidomic biomarkers for the prediction of cardiovascular outcomes in coronary artery disease patients not undergoing statin treatmentZORA BIOSCIENCES OY·Filed 2015·Granted Aug 23, 2016·0 cites·18 claims
- 1657US2019086386A1USE OF CERAMIDES AND LPLs IN DIAGNOSING CVDZORA BIOSCIENCES OY·Filed 2018·Application pending·0 cites
- 1755US9841431B2Lipidomic biomarkers for identification of high-risk coronary artery disease patientsZORA BIOSCIENCES OY·Filed 2015·Granted Dec 12, 2017·0 cites·22 claims
- 1855US2017082644A1Biomarkers for sensitive detection of statin-induced muscle toxicityZORA BIOSCIENCES OY·Filed 2016·Application pending·0 cites
- 1954US9459264B2Lipidomic biomarkers for atherosclerosis and cardiovascular diseaseZORA BIOSCIENCES OY·Filed 2015·Granted Oct 4, 2016·0 cites·29 claims
- 2052US10184932B2Use of ceramides and LPLs in diagnosing CVDZORA BIOSCIENCES OY·Filed 2016·Granted Jan 22, 2019·0 cites·3 claims
- 2150US9459265B2Lipidomic biomarkers for the prediction of cardiovascular outcomes in coronary artery disease patients undergoing statin treatmentZORA BIOSCIENCES OY·Filed 2015·Granted Oct 4, 2016·0 cites·21 claims
- 2250US2016363602A1Lipidomic biomarkers for the prediction of cardiovascular outcomes in coronary artery disease patients undergoing statin treatmentZORA BIOSCIENCES OY·Filed 2016·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →